Consistent with these findings, analysis of a large data set consisting prostate tumours9, 10 showed a significant inverse correlation between BTG2 and SETD1A mRNA expression in tumours, an effect that was most pronounced in lower-grade prostate tumours (Gleason score ≤6). Here, BTG2 is linked to prostate neoplasm.